Hyperglycemia increases the risk of death in extremely preterm baboons

Pediatric Research

Volumn 73, Issue 3, 2013, Pages 337-343

  Blanco, Cynthia L ^a   McGill Vargas, Lisa L ^a   McCurnin, Donald ^a   Quinn, Amy R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; GLUCOSE; STEROID;

ARTICLE; BABOON; BIRTH WEIGHT; CAUSE OF DEATH; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HYPERGLYCEMIA; KIDNEY FAILURE; MALE; METABOLIC ACIDOSIS; NONHUMAN; OXYGENATION; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; SEPSIS;

ANIMALS; ANIMALS, NEWBORN; BIRTH WEIGHT; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERGLYCEMIA; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; LOGISTIC MODELS; MALE; PAPIO; SEX FACTORS;

EID: 84874070582     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2012.184     Document Type: Article

References (40)

1. Garg R, Agthe AG, Donohue PK, Lehmann CU. Hyperglycemia and retinopathy of prematurity in very low birth weight infants. J Perinatol 2003;23:186-94.
2. Alexandrou G, Skiöld B, Karlén J, et al. Early hyperglycemia is a risk factor for death and white matter reduction in preterm infants. Pediatrics 2010;125:e584-91.
3. Blanco CL, Baillargeon JG, Morrison RL, Gong AK. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol 2006;26:737-41.
4. Hall NJ, Peters M, Eaton S, Pierro A. Hyperglycemia is associated with increased morbidity and mortality rates in neonates with necrotizing enterocolitis. J Pediatr Surg 2004;39:898-901; discussion 898-901.
5. Liechty EA. The resistant premie: documenting the prevalence of hyperglycemia in the extremely low birth weight infant. J Pediatr 2010;157:699-700.
6. Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 2006;118:1811-8.
7. Kaempf JW, Kaempf AJ, Wu Y, Stawarz M, Niemeyer J, Grunkemeier G. Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity. J Perinatol 2011;31:251-7.
8. Kao LS, Morris BH, Lally KP, Stewart CD, Huseby V, Kennedy KA. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. J Perinatol 2006;26:730-6.
9. Mitanchez-Mokhtari D, Lahlou N, Kieffer F, Magny JF, Roger M, Voyer M. Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. Pediatrics 2004;113(3 Pt 1):537-41.
10. Chacko SK, Ordonez J, Sauer PJ, Sunehag AL. Gluconeogenesis is not regulated by either glucose or insulin in extremely low birth weight infants receiving total parenteral nutrition. J Pediatr 2011;158:891-6.
11. Blanco CL, Liang H, Joya-Galeana J, DeFronzo RA, McCurnin D, Musi N. The ontogeny of insulin signaling in the preterm baboon model. Endocrinology 2010;151:1990-7.
12. Escobedo MB, Hilliard JL, Smith F, et al. A baboon model of bronchopulmonary dysplasia. I. Clinical features. Exp Mol Pathol 1982;37:323-34.
13. McCurnin D, Clyman RI. Effects of a patent ductus arteriosus on postprandial mesenteric perfusion in premature baboons. Pediatrics 2008;122:e1262-7.
14. Chavez AO, Lopez-Alvarenga JC, Tejero ME, et al. Physiological and molecular determinants of insulin action in the baboon. Diabetes 2008;57:899-908.
15. Guardado-Mendoza R, Dick EJ Jr, Jimenez-Ceja LM, et al. Spontaneous pathology of the baboon endocrine system. J Med Primatol 2009;38:383-9.
16. van der Lugt NM, Smits-Wintjens VE, van Zwieten PH, Walther FJ. Short and long term outcome of neonatal hyperglycemia in very preterm infants: a retrospective follow-up study. BMC Pediatr 2010;10:52.
17. Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, de Marco R. Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation 1997;96:1750-4.
18. Muggeo M, Verlato G, Bonora E, et al. Long-term instability of fasting plasma glucose predicts mortality in elderly NIDDM patients: the Verona Diabetes Study. Diabetologia 1995;38:672-9.
19. Rake AJ, Srinivasan V, Nadkarni V, Kaptan R, Newth CJ. Glucose variability and survival in critically ill children: allostasis or harm? Pediatr Crit Care Med 2010;11:707-12.
20. Shiroyama K, Moriwaki K, Yuge O. The direct effect of dopamine on glucose release from primary cultured rat hepatocytes. In Vivo 1998;12:527-9.
21. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110(2 Pt 1):285-91.
22. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Prevalence and determinants of hyperglycemia in very low birth weight infants: cohort analyses of the NIRTURE study. J Pediatr 2010;157:715-9.e1-3.
23. Halliday HL, Ehrenkranz RA, Doyle LW. Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2010;1:CD001146.
24. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61.
25. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-97.
26. Preissig CM, Rigby MR, Maher KO. Glycemic control for postoperative pediatric cardiac patients. Pediatr Cardiol 2009;30:1098-104.
27. Garcia Branco R, Tasker RC, Ramos Garcia PC, Piva JP, Dias Xavier L. Glycemic control and insulin therapy in sepsis and critical illness. J Pediatr (Rio J) 2007;83:Suppl 5:S128-36.
28. Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005;58:921-4.
29. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001;51:540-4.
30. Ng SM, May JE, Emmerson AJ. Continuous insulin infusion in hyperglycaemic extremely-low- birth-weight neonates. Biol Neonate 2005;87:269- 72.
31. Beardsall K, Dunger D. Insulin therapy in preterm newborns. Early Hum Dev 2008;84:839-42.
32. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 2008;300:2886-97.
33. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003;133:5 Suppl 2:1674S-83S.
34. Hofman PL, Regan F, Jackson WE, et al. Premature birth and later insulin resistance. N Engl J Med 2004;351:2179-86.
35. Chi MM, Hoehn A, Moley KH. Metabolic changes in the glucose-induced apoptotic blastocyst suggest alterations in mitochondrial physiology. Am J Physiol Endocrinol Metab 2002;283:E226-32.
36. Wang R, Martínez-Frías ML, Graham JM Jr. Infants of diabetic mothers are at increased risk for the oculo-auriculo-vertebral sequence: a case-based and case-control approach. J Pediatr 2002;141:611-7.
37. McCurnin DC, Yoder BA, Coalson J, et al. Effect of ductus ligation on cardiopulmonary function in premature baboons. Am J Respir Crit Care Med 2005;172:1569-74.
38. Cowett RM, Farrag HM. Selected principles of perinatal-neonatal glucose metabolism. Semin Neonatol 2004;9:37-47.
39. Denne SC, Poindexter BB, Leitch CA, Ernst JA, Lemons PK, Lemons JA. Nutrition and metabolism in the high risk neonate. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine. Diseases of the Fetus and Infant. Philadelphia, PA: Mosby-Elsevier, 2006:661-91.
40. Quinn AR, Blanco CL, Perego C, et al. The ontogeny of the endocrine pancreas in the fetal/newborn baboon. J Endocrinol 2012;214:289-99.